These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 22849332

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The roles of cys124 and ser239 in the functional properties of human betaIII tubulin.
    Joe PA, Banerjee A, Ludueña RF.
    Cell Motil Cytoskeleton; 2008 Jun; 65(6):476-86. PubMed ID: 18435451
    [Abstract] [Full Text] [Related]

  • 24. Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel.
    Hari M, Yang H, Zeng C, Canizales M, Cabral F.
    Cell Motil Cytoskeleton; 2003 Sep; 56(1):45-56. PubMed ID: 12905530
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Computational study of interactions of anti-cancer drug eribulin with human tubulin isotypes.
    Rai K, Kumbhar BV, Panda D, Kunwar A.
    Phys Chem Chem Phys; 2022 Jul 13; 24(27):16694-16700. PubMed ID: 35766982
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.
    Snyder JP, Nettles JH, Cornett B, Downing KH, Nogales E.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):5312-6. PubMed ID: 11309480
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A label-free mass spectrometry method for relative quantitation of β-tubulin isotype expression in human tumor tissue.
    Miller LM, Huang Yang CP, Xiao H, Isaac S, Sève P, Dumontet C, Band Horwitz S, Hogue Angeletti R.
    Proteomics Clin Appl; 2012 Oct 24; 6(9-10):502-6. PubMed ID: 22996942
    [Abstract] [Full Text] [Related]

  • 34. Investigation of Paclitaxel Resistant R306C Mutation in β-Tubulin—A Computational Approach.
    Verma K, Ramanathan K.
    J Cell Biochem; 2015 Jul 24; 116(7):1318-24. PubMed ID: 25735511
    [Abstract] [Full Text] [Related]

  • 35. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
    Gan PP, Pasquier E, Kavallaris M.
    Cancer Res; 2007 Oct 01; 67(19):9356-63. PubMed ID: 17909044
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Biphasic kinetics of the colchicine-tubulin interaction: role of amino acids surrounding the A ring of bound colchicine molecule.
    Gupta S, Banerjee M, Poddar A, Banerjee A, Basu G, Roy D, Bhattacharyya B.
    Biochemistry; 2005 Aug 02; 44(30):10181-8. PubMed ID: 16042395
    [Abstract] [Full Text] [Related]

  • 38. Interaction of microtubule depolymerizing agent indanocine with different human αβ tubulin isotypes.
    Kumbhar BV, Panda D, Kunwar A.
    PLoS One; 2018 Aug 02; 13(3):e0194934. PubMed ID: 29584771
    [Abstract] [Full Text] [Related]

  • 39. Understanding tubulin-Taxol interactions: mutations that impart Taxol binding to yeast tubulin.
    Gupta ML, Bode CJ, Georg GI, Himes RH.
    Proc Natl Acad Sci U S A; 2003 May 27; 100(11):6394-7. PubMed ID: 12740436
    [Abstract] [Full Text] [Related]

  • 40. Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization.
    Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JT, Fojo T, Poruchynsky MS.
    J Biol Chem; 1997 Jul 04; 272(27):17118-25. PubMed ID: 9202030
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.